These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6119249)

  • 21. Pregnancy termination: techniques, risks, and complications and their management.
    Castadot RG
    Fertil Steril; 1986 Jan; 45(1):5-17. PubMed ID: 3510916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dilatation and evacuation procedures and second-trimester abortions. The role of physician skill and hospital setting.
    Cates W; Schulz KF; Grimes DA; Horowitz AJ; Lyon FA; Kravitz FH; Frisch MJ
    JAMA; 1982 Aug; 248(5):559-63. PubMed ID: 6285012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomised trial of hypan versus gemeprost in cervical preparation prior to second trimester termination of pregnancy.
    Zamblera D; Thilaganathan B; Parsons J
    Br J Obstet Gynaecol; 1994 Jun; 101(6):543-4. PubMed ID: 8018648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
    el-Refaey H; Hinshaw K; Templeton A
    Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extraamniotic prostaglandin F2 alpha for intrauterine death and fetal abnormality.
    Luengo J; Keirse MJ; Bennebroek Gravenhorst J
    Eur J Obstet Gynecol Reprod Biol; 1977; 7(5):325-9. PubMed ID: 299460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
    Bolognese RJ; Corson SL
    Fertil Steril; 1975 Jul; 26(7):695-9. PubMed ID: 1149900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of 16,16-dimethyl-trans delta 2 prostaglandin E1 methyl ester (gemeprost) vaginal pessaries for the termination of pregnancy in the early second trimester. A comparison with extra-amniotic prostaglandin E2.
    Cameron IT; Baird DT
    Br J Obstet Gynaecol; 1984 Nov; 91(11):1136-40. PubMed ID: 6594157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Midtrimester abortion by dilatation and evacuation versus intra-amniotic instillation of prostaglandin F2 alpha: a randomized clinical trial.
    Grimes DA; Hulka JF; McCutchen ME
    Am J Obstet Gynecol; 1980 Aug; 137(7):785-90. PubMed ID: 6996483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical dilatation before first trimester elective abortion: a comparison between laminaria and a newly developed hydrogel tent, the A rod.
    Molin A; Brundin J
    Gynecol Obstet Invest; 1992; 34(1):12-4. PubMed ID: 1526524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic antibiotics in women with a history of pelvic inflammatory disease undergoing first-trimester abortion.
    Heisterberg L
    Acta Obstet Gynecol Scand; 1987; 66(1):15-8. PubMed ID: 3300133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic antibiotics for curettage abortion.
    Grimes DA; Schulz KF; Cates W
    Am J Obstet Gynecol; 1984 Nov; 150(6):689-94. PubMed ID: 6388334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of therapeutic abortion in early pregnancy with mifepristone in combination with prostaglandin pessary.
    Rodger MW; Baird DT
    Lancet; 1987 Dec; 2(8573):1415-8. PubMed ID: 2891991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion.
    Rodger MW; Baird DT
    Br J Obstet Gynaecol; 1990 Jan; 97(1):41-5. PubMed ID: 2407284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is misoprostol the drug of choice for induced cervical ripening in early pregnancy termination?
    Platz-Christensen JJ; Nielsen S; Hamberger L
    Acta Obstet Gynecol Scand; 1995 Nov; 74(10):809-12. PubMed ID: 8533565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An open study comparing two regimens of gemeprost for the termination of pregnancy in the second trimester.
    Thong KJ; Baird DT
    Acta Obstet Gynecol Scand; 1992 Apr; 71(3):191-6. PubMed ID: 1317641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
    Baird DT; Sukcharoen N; Thong KJ
    Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical dilatation by sulprostone prior to vacuum aspiration for termination of early pregnancy.
    De Bonis F; Santin AM; Mandruzzato GP
    Eur J Obstet Gynecol Reprod Biol; 1988 Oct; 29(2):113-20. PubMed ID: 3192031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early complications after induced first-trimester abortion.
    Heisterberg L; Kringelbach M
    Acta Obstet Gynecol Scand; 1987; 66(3):201-4. PubMed ID: 3661126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of prostaglandin F2 alpha for dilating the cervical canal in performing an abortion].
    Matanyi S; Kazy Z; Pajor A
    Akush Ginekol (Mosk); 1985 Mar; (3):39-41. PubMed ID: 3161363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.